Pearson PSO
$16.86 −$0.02 (-0.12%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $16.86 0.00%
Open$16.99
Prev close$16.88
Day range$16.84 – $17.17
Volume565.5K
Market cap$10.13B
P/E (TTM)25.8
Dividend yield2.03%
PSO Stock News
Headlines matching Pearson or the PSO ticker, most recent first.
- Pearson (PSON) Was Downgraded to a Hold Rating at Citi Negative
- Pearson Target Raised to GBP13.45 From GBP13 by Citigroup Positive
- Hold Rating Reaffirmed as Pearson's Digital Push Grows but 1,335p Price Target Remains Unchanged
- Pearson (PSON) Gets a Hold From J.P. Morgan
- Pearson (PSON) Receives a Hold From Barclays
- Eli Lilly Says 52-Week Data From TOGETHER-PsO and TOGETHER-PsA Phase 3b Trials of the Concomitant Use of Taltz (Ixekizumab) and Zepbound (Tirzepatide) Vs. Taltz Alone Shows Improved and Durable Efficacy in Patients With Psoriatic Disease and Obesity
- Pearson Sees 2026 Adj. Operating Profit GBP640M-GBP685M Positive
- Pearson Declares Dividend of 8.2p
- BofA Securities Maintains Pearson(PSO.US) With Hold Rating, Raises Target Price to $17.4 Positive
- 4: Magnite | 4: Statement of changes in beneficial ownership of securities-Director PEARSON DAVID T.
- J.P. Morgan Sticks to Their Buy Rating for Pearson (PSON)
- BofA Securities Initiates Pearson(PSO.US) With Hold Rating, Announces Target Price $13.9
- Pearson And Westermann Team Up To Give German Schools Trusted Route For English Certification For Study And Work
- Pearson Cut to Neutral From Buy by UBS Negative
- Barclays Sticks to Its Hold Rating for Pearson (PSON)
No comments yet — be the first to weigh in on PSO.
Sign in to join the discussion.